Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.54 |
| ▸ | TNKS | O95271 | 2/20 | 0.47 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.47 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.44 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.44 |
| ▸ | PIM1 | P11309 | 1/20 | 0.43 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | KRAS | P01116 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16922290 | 0.84 | MAPT (0.53) | MAPTTNKSTNKS2LIMK1CDK5 | |
| SCHEMBL19325077 | 0.83 | MAPT (0.51) | MAPTTNKSTNKS2LIMK1CDK5 | |
| SCHEMBL18852792 | 0.81 | MAPT (0.43) | MAPTTNKSTNKS2LIMK1PIM1 | |
| SCHEMBL19162624 | 0.80 | TNKS (0.46) | MAPTTNKSTNKS2LIMK1CDK5 | |
| SCHEMBL19169895 | 0.80 | TNKS (0.46) | MAPTTNKSTNKS2LIMK1CDK5 | |
| SCHEMBL19161212 | 0.80 | MAPT (0.49) | MAPTTNKSTNKS2LIMK1CDK5 | |
| SCHEMBL16919837 | 0.80 | MAPT (0.49) | MAPTTNKSTNKS2LIMK1CDK5 | |
| SCHEMBL27058862 | 0.79 | PIM1 (0.48) | MAPTTNKSTNKS2LIMK1PIM1 | |
| SCHEMBL27363859 | 0.79 | MAPT (0.41) | MAPTTNKSTNKS2LIMK1PIM1 | |
| SCHEMBL16922285 | 0.79 | MAPT (0.48) | MAPTTNKSTNKS2LIMK1CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022267801-A1 | ORGANIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME, AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2022-12-29 | — | — | WO | disclosed |
| US-20180114920-A1 | Electron Transport Layer Stack for an Organic Light-Emitting Diode | NOVALED GMBH (DE) | 2018-04-26 | — | — | US | disclosed |
| US-9755159-B2 | Organic materials for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2017-09-05 | — | — | US | disclosed |
| US-9502656-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-11-22 | — | — | US | disclosed |
| US-20150243893-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-08-27 | — | — | US | disclosed |
| US-20150207082-A1 | ORGANIC MATERIALS FOR OLEDS | UNIVERSAL DISPLAY CORPORATION (US) | 2015-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150207082-A1 | ORGANIC MATERIALS FOR OLEDS | OCIAD1, OCIAD2, SLC25A21 | MAPT 559/4885TNKS 3490/4885TNKS2 3304/4885 |
| US-20180114920-A1 | Electron Transport Layer Stack for an Organic Light-Emitting Diode | SLCO4C1, SLC7A5, OCIAD1 | MAPT 434/4885TNKS 4010/4885TNKS2 4004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.